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Abstract
Shift work induces chronic circadian disturbance, which might result in increased health
risks, including cardio-metabolic diseases. Previously, we identified sCD36 as a potential
non-circadian biomarker of chronic circadian disturbance in mice. The aim of the current
study (n = 232 individuals) was to identify whether sCD36 measured in plasma can be used
as a non-circadian marker of chronic circadian disturbance in humans, which would allow its
use to measure the effects of interventions and monitoring in large-scale studies. We com-
pared levels of plasma sCD36 of day workers with recent (< 2 years) and experienced (> 5
years) night-shift workers within the Klokwerk study. We detected no differences in sCD36
levels between day workers and recent or experienced night-shift workers, measured during
a day or afternoon shift. In addition, sCD36 levels measured directly after a night shift were
not different from sCD36 levels measured during day or afternoon shifts, indicating no acute
effect of night shifts on sCD36 levels in our study. In summary, our study does not show a
relation between night-shift work experience (recent or long-term) and plasma levels of
sCD36. Since we do not know if and for which time span night-shift work is associated with
changes in sCD36 levels, and our study was relatively small and cross-sectional, further evi-
dence for an association between chronic circadian disruption and this candidate biomarker
sCD36 should be gathered from large cohort studies.
Introduction
Night-shift work is an inevitable part of our 24/7 society. Surveys in Europe estimated that
approximately 19% of the workers in the European Union (EU) work regularly at night and
17% are involved in night-shift work with permanent or rotating shifts [1]. Night-shift work
interferes with timings of normal daily activities [2], disrupting circadian rhythms of many
physiological processes. Chronic disturbed circadian rhythms result in increased risks for
long-term health effects, such as obesity, cardio-metabolic diseases [3] and potentially breast
cancer [4,5].
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Current ‘classic’ circadian biomarkers, such as melatonin, cortisol and body temperature,
are used to acquire detailed insight into acute disturbances in circadian rhythms in humans
[6], based on multiple measurements around the clock or time-standardized measurements.
In addition to these ‘classic’ circadian markers, approximately up to 10% of the transcribed
genes is under circadian control, providing additional rhythmic markers to estimate a person’s
‘body time’ that could overcome certain limitations [7]. Levels of ‘classic’ circadian markers
levels depend strongly on when in the circadian cycle the measurements were taken [8,9].
Because of their short half-life, these ‘classic’ circadian markers provide only limited insights
into the cumulative biological effects of chronic circadian disturbance, which occurs during
shift work [7–9]. A non-circadian biomarker would enable monitoring circadian disturbances
in large-scale human cohort studies and could for example be used to explore the effectiveness
of preventive measures in minimizing health risks in intervention studies or research long-
term effects. In addition, a promise of a suitable biomarker for circadian disruption would be
the ability to pick up biological differences in response to a similar history of night-shift work
experience.
Previously, we have investigated universal non-rhythmic biomarkers for chronic circadian
disturbance in mice liver [10] using a transcriptomic approach. In this previous mice study, we
identified one candidate biomarker that is also present in human blood: sCD36 [10]. Mice
serum samples showed statistically significant increased levels of sCD36 14 days after chronic
circadian disruption ended, suggesting a relatively long-term effect [10].
CD36 is a class B scavenger receptor present in many cell types and tissues. CD36 is also
present in plasma, termed sCD36 (soluble), and its levels parallel those in multiple tissues [11].
CD36 has several functions related to fatty acid regulation and immune responses (dependent
on cell type and ligand specific-binding), such as transmembrane transportation of LDL, being
an adhesion molecule, being a platelet activator, binding and uptake of long chain fatty acids.
Previously, sCD36 has been identified as a biomarker for pathological conditions associated
with metabolic dysregulation, including type 2 diabetes mellitus [12], metabolic syndrome
[13], obesity [14] and cardiovascular diseases such as atherosclerosis [15,16]. Interestingly,
ClockΔ19/Δ19 mutant Apoe-/- knock out mice show an increased expression of sCD36 in macro-
phages compared to wild type clock Apoe knock out mice, indicating that circadian regulation
is an important factor in sCD36 expression and its link to atherosclerosis [17].
The aim of this study was to investigate if the candidate marker sCD36 is a marker of both
acute and chronic circadian disturbance due to night-shift work in humans. CD36 is identified
as a potential non-rhythmic biomarker for chronic circadian disruption in mice [10], follow-
ing-up this finding, we compared levels of plasma sCD36 of day workers, short-term and long-
term night-shift workers within the Klokwerk study, an observational study among female
nurses. We split up short-term and long-term night-shift workers to assess whether we could
detect difference in response between these two groups. Underlying processes for such differ-
ences might include a potential adaptation or a selection process of individuals better capable
handling night shift work among more experienced night-shift workers, or it might reflect a
cumulative effect of long-term shift work.
Material and methods
Study design and sample collection
Study design, recruitment and inclusion criteria are described elsewhere [18]. In brief, we
included female nurses and paramedic staff aged 18–67 years in our study. We included partic-
ipants that had recently (less than 2 years ago) started working in night shifts, had long-term
experience of working in night shifts (over 5 years), or had not worked in nigh-shifts in the last
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five years before recruitment (defined as ‘day-workers’). We defined night-shift work as work-
ing in a rotating-shift schedule including night shifts at least once every six weeks. A night shift
was defined as working at least one hour between midnight and 6:00 hour. ‘Day work’ was
defined as all work that does not cover the definition of a ‘night shift’, and besides traditional
working hours during the day, this also includes morning and afternoon shifts. To participate
in the study, subjects had to agree to blood sampling and filling out the questionnaires. We
excluded current and former smokers (who quit smoking >6 months before study inclusion
and/or smoked <100 cigarettes during lifetime were considered nonsmokers [19]). We
excluded participants that were pregnant (or had been in the six months before inclusion);
were undergoing fertility treatment; had ever been diagnosed with cancer (excluding non-mel-
anoma skin cancer), had high blood pressure (using beta-blockers), or diagnosed cardiovascu-
lar disease; used melatonin supplementation or medication for chronic disorders including
diabetes. We approached potentially eligible participants in five Dutch hospitals. All partici-
pants signed an informed consent. Inclusion of the participants took place between February
2015 and February 2017. The study was approved by the Institutional Review Board of the
University Medical Centre Utrecht, the Netherlands (14-611D, NL51501.041.14). All partici-
pants signed an informed consent.
We collected non-fasted blood samples during time-periods in which study participants did
not conduct night-shift work (defined as a day session). During these day sessions, samples
were ideally collected on days and times when participants were least disrupted by their work-
ing schedule: while working afternoon shifts (i.e. their working schedule did not affect their
preferred time of waking up) and as long as possible after the last period working night shifts.
We aimed to collect blood samples twice per participant during day sessions (during two sepa-
rate sessions). In addition, for night-shift workers we collected one blood sample in the morn-
ing immediately after a night-shift session. Blood sampling occurred using the standard
phlebotomy technique of venipuncture of forearms veins. EDTA plasma samples were stored
at -80˚C until further processing.
Covariates
We acquired participant characteristics including age, education, marital status, night-shift
work experience (including history of night-shift work, duration in total years of shift work
and intensity in number of shifts per month), and recent infections by a questionnaire. Chron-
otype was self-assessed by the participants using an item of the Horne-Ostberg scale [20] on
diurnal preference with five categories (obvious morning preference, more morning than
evening preference, more evening than morning preference, obvious evening preference, no
specific type). This self-assessment of one’s chronotype gave a similar result (R-square of 0.8)
to the 19-item questionnaire in a validation study by Roenneberg et al. [21]. We measured
weight and height and calculated body mass index (BMI) dividing weight in kilograms by
height in meters squared. We recorded the time and date of blood sampling for each collected
blood sample. In addition, we recorded time of waking up for a subset (n = 204 samples) of the
study population (n = 355 samples). This allowed us to express time of blood sampling as
‘wall-clock time’ and as ‘time since waking up’. (Absence of) circadian variation in plasma
sCD36 levels was assessed graphically and by assuming a 24hr cyclical trend and assessing the
linear effect of ‘time of blood sampling’ on the cyclical variation by calculating “sin(2�pi� time
of blood sampling /24)” and “cos(2�pi� time of blood sampling /24)”, and incorporating both
functions in the regression model. Meal timing was assessed using 24hr logs for a subset
(n = 205 samples). We asked our study participants to specify their timing of eating and type
of nutrition (product and quantity). We calculated the timing of last meal before blood draw.
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sCD36 analysis
We measured plasma CD36 concentrations by an in-house ELISA assay as previously
described [22]. In brief, a pool of EDTA plasma was used to produce a standard concentration
curve, and phosphate-buffered saline served as background. Absorptions were calculated rela-
tive to the standard EDTA plasma pool and expressed as relative units. Internal controls con-
sisting of another EDTA plasma pool were run in two dilutions in duplicates on each plate.
Following a standardized freeze-thaw procedure [23], samples were run in two dilutions, and
results are given as mean concentrations. Analysis was blinded; however, multiple samples
from an individual were always analyzed in one run. Analytical runs were accepted if the inter-
nal controls were within ± 1.5 SD from mean, however, the majority were within ± 1 SD.
Mean intra-assay coefficient of variation of duplicates was 7%, and total day-to-day assay coef-
ficient of variation was 17.5% (internal controls).
Data management
Less than 10% of the covariate-values were missing, which we imputed using “multivariate
imputation by chained equations” (MICE) package in R (‘pmm-method’) with a single itera-
tion [24]. We included information on the missing data pattern (S1 Appendix). Two sCD36
measurements were identified as outliers and the corresponding observations were removed
from the database. One of these observations was identified as an outlier due to long fasting
period prior to drawing blood (15 hours).
Statistical analysis
We used a box plot to show sCD36 concentrations in samples collected during a day shift in
day workers, recent night-shift workers (<2 years of night-shift-work experience), and experi-
enced night-shift workers (�5 years employed in a night-shift-work job), and used a non-
parametric Kruskal-Wallis test for significant differences in the means between these groups.
Similarly, we used a box plot to show log-transformed sCD36 concentrations of samples col-
lected during a night-shift session and samples collected during a day-shift session among
night-shift workers and used a non-parametric Wilcoxon test for significant differences
between these groups.
We used a scatter-plot to illustrate (wall-clock) the potential dependency of sCD36 levels on
timing of blood sampling for night-shift workers during a night-shift session, night-shift work-
ers during a day-shift session, and day-workers during a day-shift session. In addition, we plot-
ted sCD36 levels in blood versus the difference of timing in minutes between the last meal >50
kcal and timing of blood draw (S2 Appendix).
We conducted linear-regression mixed models to assess differences between day workers
and night-shift workers in log-transformed sCD36 concentrations in samples collected dur-
ing a day shift. Subject ID was included as random variable. In model 1, analyses were cor-
rected for age, BMI, recent infection, season (winter vs. summer time), and chronotype. We
assessed the influence of the corrections for BMI, since circulating sCD36 is associated with
obesity [25]. In addition, since the timing of blood draw was not standardized, we further
adjusted analyses for blood sampling time (wall-clock time), and time since waking up as a
proxy for an individual’s relative biological time. Finally, we adjusted our analyses for
chronotype, since night workers describe themselves more often as evening types than day
workers. In addition, we conducted analyses among morning types only, among evening
types only, among recent night workers and controls, among experienced night workers
and controls, among overweight individuals (BMI �25), and among non-overweight (BMI
<25). We provided additional estimates from multiple regression of associations between
Plasma sCD36 as non-circadian marker of chronic circadian disturbance
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these covariates and sCD36 concentrations in S3 Appendix. To be able to exclude a possible
effect of night-shift work in the past, we also analyzed the effect of night-shift work in a sub-
set where control participants whom previously performed night work were excluded (S4
Appendix. Analyses using a subset of controls whom did not previously worked night
shifts). To further research the variability due to night-shift work experience, we included
additional analyses regarding duration in total years of shift work and intensity in number
of shifts per month and CD36 concentration (S5 Appendix).To estimate the proportion of
the total variance in sCD36 levels that was due to between-worker variability we calculated
the Intraclass Correlation Coefficients (ICCworker).
To investigate if sCD36 levels are related to acute effects of working in a night shift within
workers we performed a second set of analyses, model 2. In this analysis, we assessed the differ-
ence in log-transformed sCD36 concentrations between samples collected during a night-shift
session and samples collected during a day shift session among night-shift workers, using the
same models and sensitivity analyses as described above.
Results
Description of the study population
Table 1 provides an overview of the study population that consisted of 140 night-shift workers
and 89 day workers, contributing 355 blood samples in total. For a proportion of the study
population (n = 149, of which 76 where night-shift workers, 21 recently started with working
night shifts (<2 years), and 55 were more experienced (�5 years)) only one sample collected
during a day session was available, and no dietary information was available. The majority of
blood samples were collected in the winter, 41.5% of the study participants had a BMI�25,
and 15.4% had a recent infection. Median age of the study population was 42 years (ranging
from 19 to 65).
Table 1. Description of the study population (total number of individuals = 230, total number of observations = 355).
Variable
N Recent night-workers
(number of samples)
n = 36
(45 day-shift samples, 14 night-shift samples)
N Experienced night workers
(number of samples)
n = 104
(141 day-shift samples, 48 night-shift samples)
N Day workers
(number of samples)
n = 89
(107 day-shift samples)
Season samples were collecteda 287 winter; 62 summer
Recent night workers Experienced night workers Day workers
Mean age (sd) 30 (10) 42 (11) 44 (13)
Mean BMI (sd) 23.2 (3.9) 24.6 (4.1) 24.9 (4.2)
Percentage samples collected in wintera 85.7% 88.2% 91.0%
Percentage of participants with a recent infectiona 8.8% 11.1% 14.0%
Mean years of night-shift work experience (sd) 1.3 (0.8) 18.0 (10.9) -
Chronotypea
Clearly morning person 15.8% 11.3% 24.1%
More morning than evening person 18.4% 30.2% 34.1%
More evening than morning person 31.6% 22.6% 19.8%
Clearly evening person 18.4% 16.0% 7.7%
No preference 15.8% 19.8% 14.3%
a Missing data excluded from frequency table
https://doi.org/10.1371/journal.pone.0223522.t001
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Analysis of sCD36
In the measurements collected during the day sessions ICCworker was 29.2% among day work-
ers and 37.0% among night workers, indicating that the majority of variation in sCD36 levels
was not due to between-worker variation, but due to other factors such as day-to-day
variation.
We investigated if sCD36 levels were dependent of timing of blood sampling (wall-clock
time). In Fig 1, we plot log-transformed sCD36 levels in blood versus sampling times for
night-workers during a night shift session (samples collected between 06:55 and 09:08), night-
workers during a day shift session (samples collected between 07:00 and 17:35), and day-work-
ers during a day shift session (samples collected between 07:00 and 15:25). No clear patterns in
timing of the sample collection and sCD36 levels were observed.
In addition, no clear pattern was found when we plotted sCD36 levels in blood versus the
difference of timing in minutes between the last meal >50 kcal and timing of blood draw for
night-workers during a night shift session and during a day shift session, and day-workers dur-
ing a day shift session (S2 Appendix).
Fig 1. Log-transformed sCD36 levels in blood versus sampling times for night-shift workers during a night-shift session, night-shift workers during a day-shift
session, and day workers during a day-shift session (n = 293 observations and 230 individuals).
https://doi.org/10.1371/journal.pone.0223522.g001
Plasma sCD36 as non-circadian marker of chronic circadian disturbance
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In Fig 2 plasma levels of sCD36 in samples collected from recent night-workers, experi-
enced night-workers, and day workers during day shifts are presented. Levels assessed in sam-
ples from recent night-workers were lower than levels collected from experienced night
workers and day workers (Kruskal-Wallis p-value of 0.02 for type of worker). In addition, we
included a post-hoc Wilcoxon test assessing log-transformed sCD36 concentrations of recent
night-shift workers versus day workers and experienced night-shift workers versus day work-
ers, separately (S6 Appendix). Levels assessed in samples from recent night-workers were
lower than levels collected from day workers (Wilcoxon p-value of 0.01 for type of worker).
No differences were found between experienced night-shift workers and day workers (Wil-
coxon p-value of 0.9 for type of worker).
In our main linear mixed model, we combined recent and experienced night-shift workers
into one category and observed that night-shift workers had a slight non-significant increased
level of sCD36 of 2.2% compared to day workers (CI of -12.6%, 19.4%, main model 1). This
result did not change in any of the sensitivity analyses (Table 2). When only recent or experi-
enced night-shift workers were compared to day workers, results were comparable to what we
observed in Fig 1: a lower non-significant sCD36 level amongst recent night workers
Fig 2. Log-transformed sCD36 levels in samples collected from day workers and night-shift workers during a day-shift session.
https://doi.org/10.1371/journal.pone.0223522.g002
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compared to day workers (-17.9%; 95% CI: -35.7% ─ 4.8%), while sCD36 levels among experi-
enced night-shift workers were similar to day workers (5.2%; 95% CI: -10.5% ─ 23.8%). In
addition, sCD36 levels were also similar between night-shift workers and day workers within a
subset where control participants whom previously performed night work were excluded
(5.0%, 95% CI: -13.8% - 28.0%, S4 Appendix. Analyses using a subset of controls whom did
not previously worked night shifts). The estimates of the associations between the covariates
and sCD36 from the multiple regression model, as shown in Table 2, are provided in S3
Appendix. Age was strongly associated with an increased sCD36 concentration (1.2%, 95% CI
0.5% - 1.9%).
In Fig 3 we describe sCD36 levels collected during a night-shift session and samples col-
lected during a day shift session among night-shift workers to provide an indication if sCD36
is a marker for acute circadian disruption (Wilcoxon p-value 0.4; Fig 3). Results from linear-
mixed models presented in Table 3 yield a similar inference, which did not substantially
change in most of the sensitivity analyses. An exception was a borderline significant lower
mean sCD36 level in night-shift samples collected among experienced night workers com-
pared to day samples during a day shift of the same workers (-14.6%; 95% CI: -27.2%, -0.1%),
while the mean sCD36 level among these samples in recent night workers was non-signifi-
cantly elevated (29.9% (-14.0%, 96.3%) (Table 3). Additional analyses of night-shift work expe-
rience (duration and intensity) and CD36 concentration among night-shift workers are
provided in S5 Appendix.
Table 2. Percentage difference between day workers and night-shift workers in sCD36 concentrations in samples
collected during a day-shift session.
N obs N
ind
Night-shift worker versus day worker
Main model 1� 293 230 2.2% (-12.6%, 19.4%)
p = 0.788
Not corrected for BMI 293 230 2.7% (-12.1%, 19.9%)
p = 0.740
Not corrected for chronotype 293 230 2.2% (-12.2%, 18.9%)
p = 0.779
Additionally corrected for blood sampling time 293 230 0.5% (-15.7%, 19.9%)
p = 0.953
Additionally corrected for meal timing 147 84 -1.5% (-28.2%, 35.2%)
p = 0.927
Additionally corrected for time since waking up 147 84 7.4% (-10.2%, 28.5%)
p = 0.432
Among morning types only 135 103 -7.2% (-27.0%, 17.9%)
p = 0.539
Among evening types only 95 76 -1.3% (-23.8%, 28.0%)
p = 0.924
Including only recent night workers 152 126 -17.9% (-35.7%, 4.8%)
p = 0.114
Including only experienced night workers 248 195 5.2% (-10.5%, 23.8%)
p = 0.537
Including only overweight individuals 109 85 -1.8% (-23.9%, 26.8%)
p = 0.889
Excluding overweight individuals 184 146 2.0% (-16.0%, 24.0%)
p = 0.839
�corrected for age, BMI, recent infection, season, and chronotype.
N obs = number of observations
N ind = number of individuals
https://doi.org/10.1371/journal.pone.0223522.t002
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Discussion
In this study, we compared levels of plasma sCD36 of short-term (< 2 years), long-term (> 5
years) night-shift workers and day workers within the Klokwerk study. The results described
in the current study do not provide indications for a relation between night-shift work experi-
ence (recent or long-term) and levels of sCD36 in plasma when the analysis was adjusted for
potential confounding factors.
There was no immediate effect of a night shift on sCD36 levels measured in the blood the
morning immediately after. There are some limitations of this study that could have influenced
the results. The ICCworker indicated that the variation in sCD36 levels between workers was
only slightly higher than the variation from day-to-day, which makes it difficult to distinguish
night-shift workers from day-workers in this analysis. Due to practical considerations, partici-
pants were not instructed to fast before blood sample collection. Previous data indicated an
acute effect of food consumption on sCD36 levels [26]. We did not find such an effect in our
data. The high level of variation from day-to-day was not explained by differences in moment
of blood sampling with respect to meal timing. Among the day workers in the current study
there was a high proportion of workers (56.1%) that have worked in night-shifts before they
Fig 3. Log-transformed sCD36 levels in samples collected during night-shift sessions and day-shift sessions among night-shift workers.
https://doi.org/10.1371/journal.pone.0223522.g003
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became day workers (more than 5 years ago). Considering our hypothesis of a long-term effect
of shift-work on sCD36 levels, there is a possibility that such previous shift work experience
influenced sCD36 levels in our study. The effects of external influences on sCD36 might how-
ever also be reversible, which was indicated in previous studies for some specific cases (follow-
ing participants after weight loss and gastric bypass) [27,28]. Within sensitivity analyses
among a subset without participants whom previously worked night shifts (S4 Appendix.
Analyses using a subset of controls whom did not previously worked night shifts) we did not
see stronger effects of night-shift work on sCD36 levels, but this might be because lack of
power (only 39 control subject did never work night shifts).
Our rationale to split up short-term and long-term night-shift workers was to assess
whether we could detect potential adaptation or a selection process, or cumulative effects
among more experienced night-shift workers that might lead to a different response in the
effect on CD36. As we did not see clear differences, we combined the experienced and less-
experienced groups to increase statistical power in our analyses. The lack of differences
between night-shift workers and day workers is in contrast with our previous study in mice, in
which chronic circadian disturbance was related to an increase in sCD36 [10]. What contrib-
utes to this contrast in findings are the differences between the well-controlled and uniform
mouse population and the heterogeneous human population—both in terms of heterogeneity
among humans and the blood sampling in relation to exposure as well as the less standardized
Table 3. Percentage difference in sCD36 concentrations between samples collected during a night-shift session
and samples collected during a day-shift session among night-shift workers.
N obs N
Ind
Night-shift session versus day shift session
Main model 2� 248 141 -7.8% (-20.7%, 7.1%)
p = 0.287
Not corrected for BMI 248 141 -8.0% (-20.9%, 6.9%)
p = 0.277
Not corrected for chronotype 248 141 -7.8% (-20.7%, 7.1%)
p = 0.286
Additionally corrected for blood sampling time 248 141 -12.8% (-36.5%, 19.9%)
p = 0.399
Additionally corrected for meal timing 174 67 -14.4% (-28.2%, 2.2%)
p = 0.0862
Additionally corrected for time since waking up 174 67 -3.6% (-29.8%, 32.4%)
p = 0.822
Among morning types only 99 53 -10.6% (-31.3%, 16.4%)
p = 0.405
Among evening types only 90 52 4.1% (-18.3%, 32.8%)
p = 0.744
Among recent night workers only 59 36 29.9% (-14.0%, 96.3%)
p = 0.214
Among experienced night workers only 189 105 -14.6% (-27.2%, 0.1%)
p = 0.0513
Including only overweight individuals 91 51 -14.1% (-33.2%, 10.4%)
p = 0.235
Excluding overweight individuals 157 93 -6.7% (-22.8%, 12.7%)
p = 0.471
�corrected for age, BMI, recent infection, season, and chronotype.
N obs = number of observations
N ind = number of individuals
https://doi.org/10.1371/journal.pone.0223522.t003
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exposure. The exposure scenarios between the two studies were also different in the sense that
in the current study within humans we compared sCD36 levels in real life, with less extreme
exposure scenarios compared to the mice study. In addition, interspecies differences might
play a role.
In our study sCD36 levels did not seem affected immediately after a night shift compared to
a day shift either. sCD36 levels of experienced night workers seemed less affected by a night-
shift session in terms of directions of effect compared to recent night workers, a possible indi-
cation for the bias known as ‘the healthy-worker effect’. Since this is a cross-sectional study, we
cannot make sure shift workers stopped working night shifts due to health reasons, leaving a
relatively healthy cohort of workers. The different direction of effect between experienced
night workers and recent night workers might also indicate that night work experience might
be a possible effect modifier in the association between night-shift work and sCD36. Perhaps
the time span of previous night-shift work experience is relevant. In other words, night-shift
work might be a cumulative exposure, which is visible after a certain number of years of night-
shift work experience. As for the control group, time-since-exposure is also relevant, or the
number of years since the last night shift before the effects on sCD36 levels are no longer visi-
ble. Since we do not know if and for which time span night-shift work is associated with
changes in sCD36 levels, our study design may not be optimal and could play a role in our
findings. Further evidence could be gathered in large cohort studies.
Our results do not provide evidence that sCD36 can be used as a biomarker for acute or
chronic circadian disturbance in humans as we previously hypothesized. However, these
results should be carefully interpreted and more research into this potential marker for chronic
disturbance is required.
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2. van de Langenberg D, Vlaanderen JJ, Dollé ME, Rookus MA, van Kerkhof LW, Vermeulen RC. Diet,
Physical Activity, and Daylight Exposure Patterns in Night-Shift Workers and Day Workers. Ann Work
Expo Heal [Internet]. 2018 Dec 14 [cited 2018 Dec 21]; Available from: https://academic.oup.com/
annweh/advance-article/doi/10.1093/annweh/wxy097/5248266
3. Drake CL, Roehrs T, Richardson G, Walsh JK RT. Shift Work Sleep Disorder: Prevalence and Conse-
quences Beyond that of Symptomatic Day Workers [Internet]. Sleep. 2004 [cited 2014 Jan 27]. Avail-
able from: http://journalsleep.org/ViewAbstract.aspx?pid=26073
4. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts
and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst [Internet].
2001 Oct 17 [cited 2014 Jan 27]; 93(20):1563–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/
11604480 https://doi.org/10.1093/jnci/93.20.1563 PMID: 11604480
5. Van Dycke KCG, Rodenburg W, van Oostrom CTM, van Kerkhof LWM, Pennings JLA, Roenneberg T,
et al. Chronically Alternating Light Cycles Increase Breast Cancer Risk in Mice. Curr Biol [Internet].
2015 Jul [cited 2015 Jul 20]; 25(14):1932–7. Available from: http://www.sciencedirect.com/science/
article/pii/S0960982215006776 https://doi.org/10.1016/j.cub.2015.06.012 PMID: 26196479
6. Mirick DK, Davis S. Melatonin as a biomarker of circadian dysregulation. Cancer Epidemiol Biomarkers
Prev [Internet]. 2008 Dec [cited 2014 Jan 27]; 17(12):3306–13. Available from: http://www.ncbi.nlm.nih.
gov/pubmed/19064543 https://doi.org/10.1158/1055-9965.EPI-08-0605 PMID: 19064543
7. Ueda HR, Chen W, Minami Y, Honma S, Honma K, Iino M, et al. Molecular-timetable methods for detec-
tion of body time and rhythm disorders from single-time-point genome-wide expression profiles. Proc
Natl Acad Sci [Internet]. 2004 Aug 3 [cited 2019 Apr 24]; 101(31):11227–32. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/15273285 https://doi.org/10.1073/pnas.0401882101 PMID: 15273285
8. Braun R, Kath WL, Iwanaszko M, Kula-Eversole E, Abbott SM, Reid KJ, et al. Universal method for
robust detection of circadian state from gene expression. Proc Natl Acad Sci [Internet]. National Acad-
emy of Sciences; 2018 Sep 25 [cited 2019 Apr 24]; 115(39):E9247–56. Available from: https://www.
pnas.org/content/115/39/E9247 https://doi.org/10.1073/pnas.1800314115 PMID: 30201705
9. Wittenbrink N, Ananthasubramaniam B, Münch M, Koller B, Maier B, Weschke C, et al. High-accuracy
determination of internal circadian time from a single blood sample. J Clin Invest [Internet]. 2018 Aug 31
[cited 2019 Apr 24]; 128(9):3826–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29953415
https://doi.org/10.1172/JCI120874 PMID: 29953415
10. Van Dycke KCG, Pennings JLA, van Oostrom CTM, van Kerkhof LWM, van Steeg H, van der Horst
GTJ, et al. Biomarkers for circadian rhythm disruption independent of time of day. PLoS One [Internet].
Public Library of Science; 2015 Jan 18 [cited 2016 Mar 15]; 10(5):e0127075. Available from: http://
journals.plos.org/plosone/article?id=10.1371/journal.pone.0127075 https://doi.org/10.1371/journal.
pone.0127075 PMID: 25984797
11. Koonen DPY, Jensen MK, Handberg A. Soluble CD36− a marker of the (pathophysiological) role of
CD36 in the metabolic syndrome? Arch Physiol Biochem. 2011 May; 117(2):57–63. https://doi.org/10.
3109/13813455.2010.543136 PMID: 21250778
12. Handberg A, Levin K, Højlund K, Beck-Nielsen H. Identification of the Oxidized Low-Density Lipoprotein
Scavenger Receptor CD36 in Plasma. Circulation [Internet]. 2006 Sep 12 [cited 2018 Dec 21]; 114
(11):1169–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16952981 https://doi.org/10.1161/
CIRCULATIONAHA.106.626135 PMID: 16952981
13. Koonen DPY, Jensen MK, Handberg A. Soluble CD36− a marker of the (pathophysiological) role of
CD36 in the metabolic syndrome? Arch Physiol Biochem [Internet]. 2011 May 21 [cited 2018 Dec 21];
117(2):57–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21250778 https://doi.org/10.3109/
13813455.2010.543136 PMID: 21250778
14. Knøsgaard L, Thomsen SB, Støckel M, Vestergaard H, Handberg A. Circulating sCD36 is associated
with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals. Nutr
Diabetes [Internet]. Nature Publishing Group; 2014 Apr 7 [cited 2018 Dec 21]; 4(4):e114. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/24710072
Plasma sCD36 as non-circadian marker of chronic circadian disturbance
PLOS ONE | https://doi.org/10.1371/journal.pone.0223522 October 24, 2019 13 / 14
15. Pan X, Jiang X-C, Hussain MM. Impaired Cholesterol Metabolism and Enhanced Atherosclerosis in
Clock Mutant Mice. Circulation [Internet]. 2013 Oct 15 [cited 2018 Dec 21]; 128(16):1758–69. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/24014832 https://doi.org/10.1161/CIRCULATIONAHA.113.
002885 PMID: 24014832
16. Liani R, Halvorsen B, Sestili S, Handberg A, Santilli F, Vazzana N, et al. Plasma levels of soluble CD36,
platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. Free
Radic Biol Med [Internet]. 2012 Apr 15 [cited 2018 Dec 21]; 52(8):1318–24. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/22343420 https://doi.org/10.1016/j.freeradbiomed.2012.02.012 PMID:
22343420
17. Pan X, Jiang X-C, Hussain MM. Impaired Cholesterol Metabolism and Enhanced Atherosclerosis in
Clock Mutant Mice. Circulation. 2013 Oct; 128(16):1758–69. https://doi.org/10.1161/
CIRCULATIONAHA.113.002885 PMID: 24014832
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